Prostate Cancer Clinical Trials in Oklahoma City, Oklahoma

8 studies are recruiting for prostate cancer in Oklahoma City, Oklahoma right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

   This study will explore whether a combination of the investigational drug mevrometostat (PF-06821497) and enzalutamide will work better than taking enzalutamide alone in participants with mCSPC who are ARPI naïve and have not yet received chemotherapy in the mCSPC setting.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   OU Health Medical Center, Oklahoma City, Oklahoma

   Locations

   319 in total

   Run by

   Pfizer

   See if you can join NCT07028853 on ClinicalTrials.gov

2. Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno)

   The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prespecified cancers of interest. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses an…

   Stage

   Not phased

   Ages

   18 to 100

   Site

   OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma

   Run by

   University of Oklahoma

   See if you can join NCT06960798 on ClinicalTrials.gov

3. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

   The Phase 2 monotherapy portion of this study is currently enrolling and will evaluate the efficacy and safety of PC14586 (INN rezatapopt) in participants with locally advanced or metastatic solid tumors harboring a TP53 Y220C mutation. The Phase 1 portion of the study will assess the safety, toler…

   Stage

   Phase 1

   Ages

   12 and older

   Site

   University of Oklahoma, Oklahoma City, Oklahoma

   Locations

   76 in total

   Run by

   PMV Pharmaceuticals, Inc

   See if you can join NCT04585750 on ClinicalTrials.gov

4. Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

   The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and their cancer. Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen suppression is not…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Oklahoma Proton Center, Oklahoma City, Oklahoma

   Locations

   4 in total

   Run by

   Proton Collaborative Group

   See if you can join NCT01492972 on ClinicalTrials.gov

5. Protoacoustic Imaging For 3D Mapping

   The purpose of this study is to test a new imaging technology called radioacoustic imaging (RAI) that may help doctors see where radiation is being delivered during proton therapy. During proton therapy, the radiation treatment produces very small sound signals inside the body. This study will use …

   Stage

   Not phased

   Ages

   18 and older

   Site

   OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma

   Run by

   University of Oklahoma

   See if you can join NCT07832617 on ClinicalTrials.gov

6. Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors

   The goal of this clinical trial is to ensure that the mobile health application for Black patients with prostate cancer (either actively undergoing treatment or survivors) is usable and acceptable to patients, get feedback about how to improve the app and assess its usefulness in examining their qu…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Oklahoma HSC, Oklahoma City, Oklahoma

   Locations

   3 in total

   Run by

   University of Oklahoma

   See if you can join NCT06651359 on ClinicalTrials.gov

7. Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

   The purpose of this clinical trial is to evaluate radiation therapy (RT) completion rates among underrepresented cancer populations using qualitative measurements. Additionally, the study aims to assess the impact of patient navigators on supporting patients through their radiation care, as well as…

   Stage

   Not phased

   Ages

   18 and older

   Site

   OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma

   Run by

   University of Oklahoma

   See if you can join NCT07014618 on ClinicalTrials.gov

8. Connect2Care: Prostate Cancer Education and Screenings for African American Men

   Prostate cancer is the most diagnosed cancer in African American men and the second-leading cause of cancer-related death. The prostate-specific antigen (PSA) test is an early detection screening tool for prostate cancer, however, knowledge about prostate cancer and screening benefits and risks and…

   Stage

   Not phased

   Ages

   45 to 69

   Site

   TSET Health Promotion Research Center, Oklahoma City, Oklahoma

   Run by

   University of Oklahoma

   See if you can join NCT07055165 on ClinicalTrials.gov